Can a blind retina be made sensitive to infrared light? Our team shows that an engineered human TRPV1 channel, delivered by AAV, elicits robust responses without foreign proteins or nanoparticles.
🔗 bit.ly/4gt0LO5
#AcademicBlueSky #ProteinEngineering #TRPChannels #SyntheticBiology #Vision #Retina

🧬 How can we navigate the genetic complexity of inherited retinal diseases?
Our new paper in @ajhgnews.bsky.social presents RetiGene, a curated atlas of IRD genes, built with @erdc-team.bsky.social, to support diagnosis, research and therapy.
👉 bit.ly/467U1S9
#AcademicBlueSky #IRDs #VisionResearch

🔬👁️ Organoids in the spotlight!
Magdalena Renner, leading IOB’s organoid platform, shares how high-throughput organoid systems are transforming research and speeding up the path to therapies for eye diseases. Read more: bit.ly/4mquwjP
#VisionResearch #HistoBrick #Blindness #Retina #AcademicBlueSky

👏Warm congratulations to our former IOB postdoctoral fellow @fionamuellner.bsky.social on her new role as Group Leader at @dandrite.bsky.social & Associate Professor at Aarhus University — and on receiving a prestigious ERC Starting Grant!
@erc.europa.eu

This changes how we think about vision: timing coordination starts in the eye - not the brain! Check out @anbucci.bsky.social & @ffranke.bsky.social's discovery: nature.com/articles/s41...
#Neuroscience #Vision #RGCs #RetinalResearch #AcademicBlueSky #EyeResearch #ScientificDiscovery

🧠👁️ How does your eye prevent seeing a scrambled world? @anbucci.bsky.social and @ffranke.bsky.social reveal the eye's secret "clockwork": bigger axons = faster signals = perfect visual timing!
📖 Full paper nature.com/articles/s41593-025-02011-3
#Vision #AcademicSky #Neuroscience #Retina
Image ©IOB

🧬👁️Discover how research and patient care come together in the latest Novartis Live magazine — with stories from the labs and clinics shaping the future of vision.

🔗 bit.ly/4km6XZ0

#IOB #VisionScience #TranslationalResearch #Basel #Ophthalmology #AcademicSky #Novartis

What controls eye growth?
10 key insights from decades of myopia research - from retinal feedback to red light therapy, here is what we know:
🔗 onlinelibrary.wiley.com/doi/10.1111/...

#Myopia #VisionResearch #Ophthalmology #GlobalHealth #AcademicBlueSky

Image © IOB, generated with Google AI, 2025

🧬IOB researchers (@Mukhtarullah.bsky.social
@karkam.bsky.social @carlorivolta.bsky.social
@mquinodoz.bsky.social) and international team uncover genetic signatures of eye diseases in Pakistan
📖 doi.org/10.1038/s415...
#Genetics #Vision #AcademicSky

Image © IOB, generated with Google AI, Gemini

🧠 Brain efficiency doesn't need perfect organization

Random neural responses can lead to better information processing than precisely tuned ones.

www.sciencedirect.com/science/arti...

@ravadasilveira.bsky.social | image © IOB, 2025
#AcademicSky #Neuroscience #ScienceNews

🧠 How does your brain create mental maps?

New research reveals a surprisingly simple mathematical principle behind complex spatial representations! From rodents to bats, same rules apply 🐁🦇

#Neuroscience #BrainScience #ScienceNews #AcademicBluesky

Read more here: www.cell.com/neuron/fullt...

🔍 Did you ever wonder why your eyes make tiny movements even when trying to hold still?

Those movements are not a bug, they are an essential feature for sharp vision!

Here is why: www.pnas.org/doi/epub/10....

#AcademicSky #Neuroscience #Ophthalmology

Illustration ©IOB, 2025

👁️ Advancing Vision Research 👁️
Our latest study with collaborators from CSEM introduces a HistoBrick array made from a novel material mix, optimizing cryosectioning and immunohistochemistry for retinal organoids and small tissues.

📖 Learn more: rdcu.be/d5o8Z
#Organoids #AcademicSky
Picture © IOB

We are pleased to share that RhyGaze, IOB's first spin-off, has secured Series A funding with an USD 86 million investment to advance vision restoration therapy.

Read more: iob.ch/news-view-al...

#Biotech #Basel #Innovation #LifeSciences #GeneTherapy #Ophthalmology #RhyGaze #BioTechHub

✨Thrilled about our new publication in Nature Medicine! We are excited to offer a potential new avenue for treating Stargardt disease!
Read the paper here: nature.com/articles/s41...
Watch the video: iob.ch/fileadmin/ge...
Press release here: iob.ch/news-view-al...

© 2025 IOB

✨Scientific breakthrough: IOB researchers have achieved a significant advance in developing a new treatment for Stargardt disease, the most common form of inherited macular degeneration.
Read more: www.nature.com/articles/s41...
Watch full movie: iob.ch/news-view-al...
#AcademicSky #neuroscience